Alphamab Oncology
SEHK:9966
HK$ 5.10
HK$-0.12 (-2.30%)
HK$ 5.10
HK$-0.12 (-2.30%)
End-of-day quote: 05/16/2024

9966 - Alphamab Oncology Stock Prediction 2025 - 2030

4 years of reliable Alphamab Oncology stock forecast. The Wall Street analysts predict Hold for 9966. See at a glance whether SEHK:9966 will rise in the future.

HK$0.00
Forecast 2023
HK$5.90
Forecast 2025
HK$9.23
Forecast 2030
Underperform
TopGraphs Quality Ranking
Forecast 2023
HK$0.00
Forecast 2025
HK$5.90
Forecast 2030
HK$9.23
TopGraphs Quality Ranking
Underperform

Company Info

P/E
0.00
Beta
0.36
Price-to-book Ratio
2.87
Market Cap
4.58B
TEV
6.19 B
Dividend
HK$0.00
Div Yld
0.00%
Forecast 1Y
0.00%
Forecast 2Y
0.00%
Analyst Price Target
HK$7.92
Country

Alphamab Oncology Price Chart

1M 3M YTD 1Y 2Y 5Y 10Y 20Y

Alphamab Oncology Stock Forecast 2023

HK$3.33

In the last five quarters, Alphamab Oncology’s Price Target has fallen from HK$26.48 to HK$7.92 - a -70.09% decrease. Four analysts predict that Alphamab Oncology’s share price will fall in the coming year, reaching HK$3.33. This would represent a decrease of -57.95%.

-34.71%
-34.71
Last update: 05/17/2024

Highest Price Target HK$4.43

Average Price Target HK$3.33

Lowest Price Target HK$3.14

Alphamab Oncology Stock Forecast 2025

Stock Prediction for the Price of One Alphamab Oncology Share in Jan 2025.

In Jan 2025 analysts predict a share price of HK$5.44. An increase of 6.64% compared to today's share price.

Stock Prediction for the Price of One Alphamab Oncology Share in Feb 2025.

In Feb 2025 analysts predict a share price of HK$5.48. An increase of 7.47% compared to today's share price.

Stock Prediction for the Price of One Alphamab Oncology Share in Mar 2025.

In Mar 2025 analysts predict a share price of HK$5.52. An increase of 8.29% compared to today's share price.

Stock Prediction for the Price of One Alphamab Oncology Share in Apr 2025.

In Apr 2025 analysts predict a share price of HK$5.57. An increase of 9.12% compared to today's share price.

Stock Prediction for the Price of One Alphamab Oncology Share in May 2025.

In May 2025 analysts predict a share price of HK$5.61. An increase of 9.94% compared to today's share price.

Stock Prediction for the Price of One Alphamab Oncology Share in Jun 2025.

In Jun 2025 analysts predict a share price of HK$5.65. An increase of 10.77% compared to today's share price.

Stock Prediction for the Price of One Alphamab Oncology Share in Jul 2025.

In Jul 2025 analysts predict a share price of HK$5.69. An increase of 11.59% compared to today's share price.

Stock Prediction for the Price of One Alphamab Oncology Share in Aug 2025.

In Aug 2025 analysts predict a share price of HK$5.73. An increase of 12.42% compared to today's share price.

Stock Prediction for the Price of One Alphamab Oncology Share in Sep 2025.

In Sep 2025 analysts predict a share price of HK$5.78. An increase of 13.25% compared to today's share price.

Stock Prediction for the Price of One Alphamab Oncology Share in Oct 2025.

In Oct 2025 analysts predict a share price of HK$5.82. An increase of 14.07% compared to today's share price.

Stock Prediction for the Price of One Alphamab Oncology Share in Nov 2025.

In Nov 2025 analysts predict a share price of HK$5.86. An increase of 14.9% compared to today's share price.

Stock Prediction for the Price of One Alphamab Oncology Share in Dec 2025.

In Dec 2025 analysts predict a share price of HK$5.90. An increase of 15.72% compared to today's share price.

Alphamab Oncology Stock Predictions 2030

Alphamab Oncology Stock Predictions for Jan 2030.

In January 2030 analysts predict a stock price of HK$8.51. An increase of 66.81% compared to the previous month's estimate.

Alphamab Oncology Stock Predictions for Feb 2030.

In February 2030 analysts predict a stock price of HK$8.57. An increase of 68.1% compared to the previous month's estimate.

Alphamab Oncology Stock Predictions for Mar 2030.

In March 2030 analysts predict a stock price of HK$8.64. An increase of 69.39% compared to the previous month's estimate.

Alphamab Oncology Stock Predictions for Apr 2030.

In April 2030 analysts predict a stock price of HK$8.70. An increase of 70.68% compared to the previous month's estimate.

Alphamab Oncology Stock Predictions for May 2030.

In May 2030 analysts predict a stock price of HK$8.77. An increase of 71.97% compared to the previous month's estimate.

Alphamab Oncology Stock Predictions for Jun 2030.

In June 2030 analysts predict a stock price of HK$8.84. An increase of 73.26% compared to the previous month's estimate.

Alphamab Oncology Stock Predictions for Jul 2030.

In July 2030 analysts predict a stock price of HK$8.90. An increase of 74.56% compared to the previous month's estimate.

Alphamab Oncology Stock Predictions for Aug 2030.

In August 2030 analysts predict a stock price of HK$8.97. An increase of 75.85% compared to the previous month's estimate.

Alphamab Oncology Stock Predictions for Sep 2030.

In September 2030 analysts predict a stock price of HK$9.03. An increase of 77.14% compared to the previous month's estimate.

Alphamab Oncology Stock Predictions for Oct 2030.

In October 2030 analysts predict a stock price of HK$9.10. An increase of 78.43% compared to the previous month's estimate.

Alphamab Oncology Stock Predictions for Nov 2030.

In November 2030 analysts predict a stock price of HK$9.17. An increase of 79.72% compared to the previous month's estimate.

Alphamab Oncology Stock Predictions for Dec 2030.

In December 2030 analysts predict a stock price of HK$9.23. An increase of 81.01% compared to the previous month's estimate.

P/E
0.00
Beta
0.36
Price-to-book Ratio
2.87
Market Cap
4.58B
TEV
6.19 B
Dividend
HK$0.00
Div Yld
0.00%
Forecast 1Y
0.00%
Forecast 2Y
0.00%
Analyst Price Target
HK$7.92
Country

Alphamab Oncology Analyst Ratings Frequently Asked Questions

Who are the analysts watching Alphamab Oncology?

The following analysts have recently covered Alphamab Oncology:

CLSA
Jefferies LLC
Morgan Stanley
Citigroup Inc
Citigroup Inc. Research
(This information refers to the last 90 days.)

Who are the sell-side analysts watching Alphamab Oncology?

The following sell-side analysts have recently covered Alphamab Oncology:

Yan, Yonglin
Shi, Dingding
Wu, Sean
Zhou, Wangbin
(This information refers to the last 90 days.)